語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Hypertension[electronic resource] :a...
~
Brenner, Barry M., (1937-)
Hypertension[electronic resource] :a companion to Brenner and Rector's the kidney /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.1/32
書名/作者:
Hypertension : a companion to Brenner and Rector's the kidney // [edited by] Suzanne Oparil, Michael A. Weber.
其他題名:
Hypertension :
其他作者:
Oparil, Suzanne.
出版者:
Philadelphia : : Elsevier Mosby,, c2005.
面頁冊數:
xxv, 872 p. : : ill. ;; 29 cm.
附註:
Companion v. to Brenner & Rector's the kidney / edited by Barry M. Brenner. 7th ed. c2004.
標題:
Hypertension.
標題:
Hypertension - therapy.
標題:
Antihypertensive Agents - therapeutic use.
標題:
Hypertension - complications.
標題:
Hypertension - physiopathology.
標題:
Life Style.
標題:
Hypertensie.
標題:
Hipertens�ao (farmacologia;tratamento)
標題:
Cardiopatias.
ISBN:
9780721602585
ISBN:
0721602584
書目註:
Includes bibliographical references and index.
內容註:
Sect. 1. Background and history. A history of hypertension treatment -- The National High Blood Pressure Education Program -- Epidemiology of hypertension -- sect. 2. Pathophysiology. Pathophysiology of hypertension -- Blood pressure genetics -- The sympathetic nervous system in acute and chronic blood pressure elevation -- Environmental and psychosocial stress in hypertension onset and progression -- Renin -- Angiotensin-converting enzymes: properties and function -- Angiotensin-(1-7) -- The angiotensin receptors: AT b1 s and AT b2 s -- Aldosterone and mineralocorticoids -- The role of insulin resistance and compensatory hyperinsulinemia in patients with essential hypertension -- Remodeling of resistance arteries in hypertension -- Clinical applications of arterial stiffness in hypertension -- Endothelium in hypertension: nitric oxide --Endothelin in hypertension -- Natriuretic peptides -- Vasodilator peptides: CGRP, substance P, and adrenomedullin -- The Kallikrein-Kinin System as a regulator of cardiovascular and renal function -- Sect. 3. Target organ damage/cardiovascular events. The concept of total risk -- New interpretations of blood pressure: the importance of pulse pressure -- Coronary atherosclerotic sequelae of hypertension -- Left ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertension -- Renal protection in chronic kidney disease -- sect. 4. Diagnosis. Initial evaluation and follow-up assessment -- Prognostic and diagnostic value of ambulatory blood pressure monitoring -- White-coat hypertension -- Sect. 5. Treatment: general considerations. The blood pressure lowering treatment trialists' collaboration (BPLTTC) -- The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) -- The LIFE study -- The VALUE trial -- Main results from VALUE -- Clinical outcome trials of hypertension with angiotensin receptor blockers -- ACE inhibitor trials: effects in hypertension -- Critical assessment of hypertension guidelines -- Current prescribing practices -- Calcium channel blockers: controversies, lessons, and outcomes -- Nursing clinics in the management of hypertension -- Community outreach -- Medication adherence for antihypertensive therapy -- Sect. 6. Diet and nutrition. Diet: micronutrients -- Dietary approaches to hypertension management: the DASH studies -- Obesity and hypertension: impact on the cardiovascular and renal systems -- Alcohol and hypertension -- Obesity in hypertension: the role of diet and drugs -- Exercise and hypertension -- Sect. 7. Pharmacologic treatment. Initial choices in the treatment of hypertension -- Pharmacokinetics of antihypertensive drugs -- Fixed combination antihypertensive therapy -- Chronotherapeutics in the treatment of hypertension -- Sect. 8. Comorbid conditions and special populations in hypertension. Diabetes mellitus and the cardiovascular metabolic syndrome: reducing cardiovascular and renal events -- Hypertension in patients on renal replacement therapy -- Ischemic heart disease in hypertension -- Hypertension in the elderly -- Management of hypertension in Black populations -- Hypertension in pregnancy -- Hypertension in children -- Resistant hypertension -- Orthostatic hypotension and autonomic dysfunction syndromes -- Sect. 9. Individual drug classes. How antihypertensive drugs get approved in the United States -- Diuretics: mechanisms of action -- [beta]-adrenergic blockers -- [alpha]-adrenoceptor blockers -- Angiotensin-converting enzyme inhibitors -- Calcium antagonists -- Angiotensin II receptor antagonists -- Direct-acting smooth muscle vasodilators and adrenergic inhibitors -- Endothelin antagonists -- Mineralocorticoid receptor antagonists -- Vasopeptidase inhibitors -- Renin inhibitors -- Sect. 10. Secondary hypertension. Obstructive sleep apnea and hypertension -- Renovascular hypertension: diagnosis and treatment -- Adrenal cortex hypertension -- Phoechromocytoa: detection and management -- Anesthesia and hypertension -- Management of hypertensive emergencies and urgencies -- Aggressive blood pressure targets; developing effective algorithms.
摘要、提要註:
The revised and updated 2nd Edition provides a logical, practical framework for managing patients with hypertension. Today's leading experts discuss all aspects of the field b7 sfrom pathophysiology, pharmacological treatments, and lifestyle modifications to secondary hypertension and cardiovascular complications. Assesses the risks of specific pharmacological treatments * offers expert analysis of recent clinical trials * and providesDelivers strategies for managing patients with comorbid conditions such as diabetes, renal disease, and ischemic heart disease.Explains the role of vascular biology in the pathogenesis of hypertension.
電子資源:
An electronic book accessible through the World Wide Web; click for information
Hypertension[electronic resource] :a companion to Brenner and Rector's the kidney /
Hypertension
a companion to Brenner and Rector's the kidney /[electronic resource] :Hypertension :a companion to Brenner and Rector's the kidney (Online)[edited by] Suzanne Oparil, Michael A. Weber. - 2nd ed. - Philadelphia :Elsevier Mosby,c2005. - xxv, 872 p. :ill. ;29 cm.
Companion v. to Brenner & Rector's the kidney / edited by Barry M. Brenner. 7th ed. c2004.
Includes bibliographical references and index.
Sect. 1. Background and history. A history of hypertension treatment -- The National High Blood Pressure Education Program -- Epidemiology of hypertension -- sect. 2. Pathophysiology. Pathophysiology of hypertension -- Blood pressure genetics -- The sympathetic nervous system in acute and chronic blood pressure elevation -- Environmental and psychosocial stress in hypertension onset and progression -- Renin -- Angiotensin-converting enzymes: properties and function -- Angiotensin-(1-7) -- The angiotensin receptors: AT b1 s and AT b2 s -- Aldosterone and mineralocorticoids -- The role of insulin resistance and compensatory hyperinsulinemia in patients with essential hypertension -- Remodeling of resistance arteries in hypertension -- Clinical applications of arterial stiffness in hypertension -- Endothelium in hypertension: nitric oxide --Endothelin in hypertension -- Natriuretic peptides -- Vasodilator peptides: CGRP, substance P, and adrenomedullin -- The Kallikrein-Kinin System as a regulator of cardiovascular and renal function -- Sect. 3. Target organ damage/cardiovascular events. The concept of total risk -- New interpretations of blood pressure: the importance of pulse pressure -- Coronary atherosclerotic sequelae of hypertension -- Left ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertension -- Renal protection in chronic kidney disease -- sect. 4. Diagnosis. Initial evaluation and follow-up assessment -- Prognostic and diagnostic value of ambulatory blood pressure monitoring -- White-coat hypertension -- Sect. 5. Treatment: general considerations. The blood pressure lowering treatment trialists' collaboration (BPLTTC) -- The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) -- The LIFE study -- The VALUE trial -- Main results from VALUE -- Clinical outcome trials of hypertension with angiotensin receptor blockers -- ACE inhibitor trials: effects in hypertension -- Critical assessment of hypertension guidelines -- Current prescribing practices -- Calcium channel blockers: controversies, lessons, and outcomes -- Nursing clinics in the management of hypertension -- Community outreach -- Medication adherence for antihypertensive therapy -- Sect. 6. Diet and nutrition. Diet: micronutrients -- Dietary approaches to hypertension management: the DASH studies -- Obesity and hypertension: impact on the cardiovascular and renal systems -- Alcohol and hypertension -- Obesity in hypertension: the role of diet and drugs -- Exercise and hypertension -- Sect. 7. Pharmacologic treatment. Initial choices in the treatment of hypertension -- Pharmacokinetics of antihypertensive drugs -- Fixed combination antihypertensive therapy -- Chronotherapeutics in the treatment of hypertension -- Sect. 8. Comorbid conditions and special populations in hypertension. Diabetes mellitus and the cardiovascular metabolic syndrome: reducing cardiovascular and renal events -- Hypertension in patients on renal replacement therapy -- Ischemic heart disease in hypertension -- Hypertension in the elderly -- Management of hypertension in Black populations -- Hypertension in pregnancy -- Hypertension in children -- Resistant hypertension -- Orthostatic hypotension and autonomic dysfunction syndromes -- Sect. 9. Individual drug classes. How antihypertensive drugs get approved in the United States -- Diuretics: mechanisms of action -- [beta]-adrenergic blockers -- [alpha]-adrenoceptor blockers -- Angiotensin-converting enzyme inhibitors -- Calcium antagonists -- Angiotensin II receptor antagonists -- Direct-acting smooth muscle vasodilators and adrenergic inhibitors -- Endothelin antagonists -- Mineralocorticoid receptor antagonists -- Vasopeptidase inhibitors -- Renin inhibitors -- Sect. 10. Secondary hypertension. Obstructive sleep apnea and hypertension -- Renovascular hypertension: diagnosis and treatment -- Adrenal cortex hypertension -- Phoechromocytoa: detection and management -- Anesthesia and hypertension -- Management of hypertensive emergencies and urgencies -- Aggressive blood pressure targets; developing effective algorithms.
The revised and updated 2nd Edition provides a logical, practical framework for managing patients with hypertension. Today's leading experts discuss all aspects of the field b7 sfrom pathophysiology, pharmacological treatments, and lifestyle modifications to secondary hypertension and cardiovascular complications. Assesses the risks of specific pharmacological treatments * offers expert analysis of recent clinical trials * and providesDelivers strategies for managing patients with comorbid conditions such as diabetes, renal disease, and ischemic heart disease.Explains the role of vascular biology in the pathogenesis of hypertension.
Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2009.
Mode of access: World Wide Web.
ISBN: 9780721602585
Source: 30863:30865Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:
382053
Hypertension.
Index Terms--Genre/Form:
336502
Electronic books.
LC Class. No.: RC685.H8 / H76783 2005
Dewey Class. No.: 616.1/32
National Library of Medicine Call No.: 2005 E-845
Hypertension[electronic resource] :a companion to Brenner and Rector's the kidney /
LDR
:06713cam 2200385Ia 4500
001
347380
003
OCoLC
005
20110615082805.0
006
m d
007
cr cn|||||||||
008
111130s2005 paua ob 001 0 eng d
020
$a
9780721602585
020
$a
0721602584
035
$a
(OCoLC)489077447
035
$a
ocn489077447
037
$a
30863:30865
$b
Elsevier Science & Technology
$n
http://www.sciencedirect.com
040
$a
OPELS
$b
eng
$c
OPELS
$d
DMJ
049
$a
TEFA
050
1 4
$a
RC685.H8
$b
H76783 2005
060
1 4
$a
2005 E-845
060
1 4
$a
WG 340
$b
H99426 2005
082
0 4
$a
616.1/32
$2
22
245
0 0
$a
Hypertension
$h
[electronic resource] :
$b
a companion to Brenner and Rector's the kidney /
$c
[edited by] Suzanne Oparil, Michael A. Weber.
246
3
$a
Hypertension :
$b
a companion to Brenner and Rector's the kidney (Online)
250
$a
2nd ed.
260
$a
Philadelphia :
$b
Elsevier Mosby,
$c
c2005.
300
$a
xxv, 872 p. :
$b
ill. ;
$c
29 cm.
500
$a
Companion v. to Brenner & Rector's the kidney / edited by Barry M. Brenner. 7th ed. c2004.
504
$a
Includes bibliographical references and index.
505
0
$a
Sect. 1. Background and history. A history of hypertension treatment -- The National High Blood Pressure Education Program -- Epidemiology of hypertension -- sect. 2. Pathophysiology. Pathophysiology of hypertension -- Blood pressure genetics -- The sympathetic nervous system in acute and chronic blood pressure elevation -- Environmental and psychosocial stress in hypertension onset and progression -- Renin -- Angiotensin-converting enzymes: properties and function -- Angiotensin-(1-7) -- The angiotensin receptors: AT b1 s and AT b2 s -- Aldosterone and mineralocorticoids -- The role of insulin resistance and compensatory hyperinsulinemia in patients with essential hypertension -- Remodeling of resistance arteries in hypertension -- Clinical applications of arterial stiffness in hypertension -- Endothelium in hypertension: nitric oxide --Endothelin in hypertension -- Natriuretic peptides -- Vasodilator peptides: CGRP, substance P, and adrenomedullin -- The Kallikrein-Kinin System as a regulator of cardiovascular and renal function -- Sect. 3. Target organ damage/cardiovascular events. The concept of total risk -- New interpretations of blood pressure: the importance of pulse pressure -- Coronary atherosclerotic sequelae of hypertension -- Left ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertension -- Renal protection in chronic kidney disease -- sect. 4. Diagnosis. Initial evaluation and follow-up assessment -- Prognostic and diagnostic value of ambulatory blood pressure monitoring -- White-coat hypertension -- Sect. 5. Treatment: general considerations. The blood pressure lowering treatment trialists' collaboration (BPLTTC) -- The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) -- The LIFE study -- The VALUE trial -- Main results from VALUE -- Clinical outcome trials of hypertension with angiotensin receptor blockers -- ACE inhibitor trials: effects in hypertension -- Critical assessment of hypertension guidelines -- Current prescribing practices -- Calcium channel blockers: controversies, lessons, and outcomes -- Nursing clinics in the management of hypertension -- Community outreach -- Medication adherence for antihypertensive therapy -- Sect. 6. Diet and nutrition. Diet: micronutrients -- Dietary approaches to hypertension management: the DASH studies -- Obesity and hypertension: impact on the cardiovascular and renal systems -- Alcohol and hypertension -- Obesity in hypertension: the role of diet and drugs -- Exercise and hypertension -- Sect. 7. Pharmacologic treatment. Initial choices in the treatment of hypertension -- Pharmacokinetics of antihypertensive drugs -- Fixed combination antihypertensive therapy -- Chronotherapeutics in the treatment of hypertension -- Sect. 8. Comorbid conditions and special populations in hypertension. Diabetes mellitus and the cardiovascular metabolic syndrome: reducing cardiovascular and renal events -- Hypertension in patients on renal replacement therapy -- Ischemic heart disease in hypertension -- Hypertension in the elderly -- Management of hypertension in Black populations -- Hypertension in pregnancy -- Hypertension in children -- Resistant hypertension -- Orthostatic hypotension and autonomic dysfunction syndromes -- Sect. 9. Individual drug classes. How antihypertensive drugs get approved in the United States -- Diuretics: mechanisms of action -- [beta]-adrenergic blockers -- [alpha]-adrenoceptor blockers -- Angiotensin-converting enzyme inhibitors -- Calcium antagonists -- Angiotensin II receptor antagonists -- Direct-acting smooth muscle vasodilators and adrenergic inhibitors -- Endothelin antagonists -- Mineralocorticoid receptor antagonists -- Vasopeptidase inhibitors -- Renin inhibitors -- Sect. 10. Secondary hypertension. Obstructive sleep apnea and hypertension -- Renovascular hypertension: diagnosis and treatment -- Adrenal cortex hypertension -- Phoechromocytoa: detection and management -- Anesthesia and hypertension -- Management of hypertensive emergencies and urgencies -- Aggressive blood pressure targets; developing effective algorithms.
520
$a
The revised and updated 2nd Edition provides a logical, practical framework for managing patients with hypertension. Today's leading experts discuss all aspects of the field b7 sfrom pathophysiology, pharmacological treatments, and lifestyle modifications to secondary hypertension and cardiovascular complications. Assesses the risks of specific pharmacological treatments * offers expert analysis of recent clinical trials * and providesDelivers strategies for managing patients with comorbid conditions such as diabetes, renal disease, and ischemic heart disease.Explains the role of vascular biology in the pathogenesis of hypertension.
533
$a
Electronic reproduction.
$b
Amsterdam :
$c
Elsevier Science & Technology,
$d
2009.
$n
Mode of access: World Wide Web.
$n
System requirements: Web browser.
$n
Title from title screen (viewed on Dec. 9, 2009).
$n
Access may be restricted to users at subscribing institutions.
533
$a
Electronic reproduction.
$b
St. Louis, MO. :
$c
MD Consult, LLC.,
$d
[2009?].
$n
Online version of print publication
$n
Mode of access: World Wide Web.
$n
Access may be restricted to users at subscribing institutions.
650
0
$a
Hypertension.
$3
382053
650
1 2
$a
Hypertension
$x
therapy.
$3
430456
650
2 2
$a
Antihypertensive Agents
$x
therapeutic use.
$3
430457
650
2 2
$a
Hypertension
$x
complications.
$3
430458
650
2 2
$a
Hypertension
$x
physiopathology.
$3
430459
650
2 2
$a
Life Style.
$3
430460
650
1 7
$a
Hypertensie.
$2
gtt
$3
430461
650
7
$a
Hipertens�ao (farmacologia;tratamento)
$2
larpcal
$3
430462
650
7
$a
Cardiopatias.
$2
larpcal
$3
430463
655
7
$a
Electronic books.
$2
local
$3
336502
700
1
$a
Oparil, Suzanne.
$3
430453
700
1
$a
Weber, Michael A.,
$d
1942-
$3
430454
700
1
$a
Brenner, Barry M.,
$d
1937-
$t
Brenner & Rector's the kidney.
$3
430455
710
2
$a
ScienceDirect (Online service)
$3
365609
710
2
$a
MD Consult LLC.
$3
430159
776
1
$c
Original
$z
0721602584
$z
9780721602585
$w
(DLC) 2004051303
$w
(OCoLC)56567478
856
4 0
$3
ScienceDirect
$u
http://www.sciencedirect.com/science/book/9780721602585
$z
An electronic book accessible through the World Wide Web; click for information
994
$a
C0
$b
TEF
筆 0 讀者評論
多媒體
多媒體檔案
http://www.sciencedirect.com/science/book/9780721602585
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入